Symbiotec Pharmalab shares rallied as much as 7.7% on September 29, after receiving the Establishment Inspection Report from the U.S. Food and Drug Administration for its Pithampur manufacturing facility, which carried a Voluntary Action Indicated status. The Indian benchmark indices fell during the afternoon, with the SENSEX dropping 0.97% to an intraday low of 72,064.00 and the NIFTY50 tumbled 0.92% to 22,569.65. The rupee weakened past the 96 mark, touching 96.388 against the U.S. dollar, a 0.20% decline from the previous close today.

Foreign institutional investors sold shares worth ₹5,353.22 crore on Monday, while domestic institutional investors purchased equities worth ₹5,189.02 crore on a net basis, according to exchange data. The S&P BSE SENSEX fell 405.32 points, or 0.56%, to 72,366.40 at 1:25 PM, and NSE’s NIFTY50 stood at 22,665.70, marking a 114.55‑point, or 0.50%, decline. The market sentiment reflected weak global cues, a surge in crude oil prices, and a weak rupee, all contributing to the negative trajectory of the indices during the trading session again today.

The NIFTY50 index’s top losers included HDFC Life Insurance Company, Titan Company, HCL Technologies, Infosys and Eternal, while Dr. Reddy’s Laboratories, Adani Enterprises, Kotak Mahindra Bank, Adani Ports and Special Economic Zone and Tata Steel also fell. Pharmaceutical stocks such as Mankind Pharma, Dr Reddy’s, Gland Pharma and Abbott India gained during the session, lifting the Nifty Pharma index over 1% as the United States exempted certain speciality drugs from a 100% import duty rate. The exemption applies to eligible Indian drugmakers, providing zero import duty relief in the U.S., the country’s primary export market for domestic pharmaceutical companies.

Shares of Adani Group companies – Adani Enterprises Ltd, Adani Power Ltd, Adani Ports and Special Economic Zone Ltd (APSEZ) and Adani Transmission Ltd, now Adani Energy Solutions Ltd – were mostly trading in the green zone on September 29. The group settled proceedings initiated by SEBI over alleged violations of minimum public shareholding norms by paying a settlement amount of ₹1.48 crore. The settlement covers the four companies and their directors. The complaints were received by SEBI in June and July 2020, alleging non‑compliance with MPS requirements by certain listed Adani Group companies.

Azad Engineering shares rallied as much as 10.1% to an intraday high of ₹2,998 after Goldman Sachs highlighted the company’s inauguration of two exclusive lean manufacturing facilities for GE Vernova’s Gas Power business, a key medium‑term growth driver. NCC stock climbed 5.38% to a session peak of ₹137.30 after securing a ₹1,076.71‑crore letter of award from Andhra Pradesh for supplying fresh water under the Multi Village Scheme, expected to be executed over 24 months. AXISCADE Technologies surged 10% to its upper circuit limit at ₹2,067.40 following a block deal of ₹829.72 crore, while TCI Express gained 20% to ₹583.20 after a block deal worth ₹29.59 crore.

Symbiotec Pharmalab’s rally continued as the company received its Establishment Inspection Report from the U.S. FDA, with a Voluntary Action Indicated status, for its Pithampur facility. Coforge shares climbed 2.3% to an intraday high of ₹1,813.80 after its board appointed Akhil Gupta as Chairperson and Non‑Executive Independent Director; Gupta’s five‑year term begins on September 29, 2026. Varmora Granito debuted at ₹155 on the NSE, a 4.73% premium over its IPO issue price of ₹148, while on the BSE it opened at ₹152, up 2.70% from the issue price. The ₹708.02‑crore IPO comprised a fresh issuance of ₹320 crore and an offer‑for‑sale component of ₹388.02 crore by investor Katsura Investments.